This episode of DeviceTalks AI emphasizes the prognostic and point-of-care decision-making power of AI in oncology while addressing real-world implementation issues from regulation and liability to clinician trust and adoption, through conversations with leaders at GE HealthCare and Catalyze Healthcare.

In the first segment, Ben Newton, General Manager of Oncology at GE HealthCare describes likely future advances in multimodal computing, which could parse diverse datasets from pathology, imaging, genomics and other domains to predict likely outcomes in given treatment scenarios. Newton also emphasized AI's ability to help overwhelmed physicians by alleviating workflow bottlenecks and assisting with point-of-care decision making. Despite the promise, he underscored that such advances rely on incorporating clinicians’ valuable perspective when developing these AI systems and partnerships with other industry stakeholders, such as cloud partners like AWS and academic centers or hospitals, to access data and create foundation models.

In the second segment, Haley Schwartz, CEO at Catalyze Healthcare, highlights the potential of using AI for screening applications as an initial stepping stone to build trust and adoption. She also notes that potential headwinds for hospital adoption of AI are questions related to legal liability and reimbursement impacts. In addition, Schwartz emphasizes the importance of physician involvement, especially during the early stages of AI integration into healthcare.

Join us for the next episode of DeviceTalks AI, featuring a keynote interview with Helen Merianos, Head of Sanofi’s R&D Portfolio Strategy.

Thank you to our sponsors, some of whom include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing invaluable support. 
www.catalyzehealthcare.com www.smarttrak.com

Tune in and subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

WATCH, LISTEN, and READ. Thank you for supporting DeviceTalks AI!

Read Now: https://www.medicaldesignandoutsourcing.com/ai-holy-grail-devices-disease-digital-healthcare/
Watch Now: youtu.be/XtGbJ-2Jyro

GE HealthCare pulls back the curtain on its unmatched AI clearances; Catalyze tackles AI trust gap

In this episode, we visit with Rebecca Seidel, president of Medtronic’s cardiac ablation solutions group, about the future of pulsed-field ablation and what it means for the electrophysiology sector.

Host Tom Salemi also visits with biomedical researcher Jeff Karp to discuss his new book, LIT: Life Ignition Tools: Use Nature's Playbook to Energize Your Brain, Spark Ideas, and Ignite Action Kindle Edition. Use the code LIT25 to save 25% off the registration price of DeviceTalks Boston and you could win a free copy. Karp will also be at DeviceTalks Boston’s opening reception on April 30. Come meet the author and noted medtech innovator. 

Finally, we get a #DTBoston2024 speaker preview – Scott Nelson, CEO of FastWave Medical, one of two IVL companies we’ll have at the conference!

Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network

Medtronic’s Seidel Maps out Future for Electrophysiology, Pulsed-Field Ablation Portfolio

In this episode, we talk to Matt Casella from Richtech about the Adam bartending robot, and then to Chris Padwick from John Deere about creating vision models for spraying weeds in the field. Both interviews occurred during the NVIDIA GTC24 event in March, and both companies leverage NVIDIA technology in their robotic solutions. 
We also cover the breaking news from the week, including the launch of the new Boston Dynamics Electric Atlas
Richtech Robotics: https://www.richtechrobotics.com/
John Deere Autonomous Solutions: https://www.deere.com/en/sprayers/see-spray/
Boston Dynamics Electric Atlas: https://bostondynamics.com/atlas/

From the barn to the bar: AI powered robots

In the final episode of MedtechWOMEN Talks season one, we are joined by YJ Oh, SVP US Sales, Marketing and Commercial Operations at Edwards Lifesciences, who takes us through the intricate process of medical device commercialization. Starting with her unique entry into the medtech industry, YJ shares her comprehensive journey from sales to global marketing, emphasizing the significant role of upstream marketing in shaping product development and downstream efforts in executing commercial strategies.

In the discussion, YJ highlights the criticality of understanding market needs right from the inception of a product idea, ensuring that every development phase aligns with customer insights and real-world applicability. She provides a glimpse into the key collaborations across various departments and touches on the essential feedback mechanisms in place, ensuring devices meet the stringent requirements and expectations set forth by both regulatory bodies and the end-users, primarily physicians. Her insights extend into the strategic considerations for global market penetration, discussing how different regulatory landscapes affect the accessibility and success of medical devices across borders.

TL;DR – Key Takeaways:
- The integration of market insights from the beginning is crucial for successful medical device commercialization.
- Collaborative efforts across various functions are vital to address the comprehensive demands of product development.
- Strategic global considerations are imperative to navigate varying regulatory and market conditions effectively.

Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical!

https://aptyx.com/ 
https://catalyzehealthcare.com/ 
https://confluentmedical.com/
https://www.cretex.com/

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

Thank you for listening to MedtechWOMEN Talks!

How do I take an approved medical device to market? with YJ Oh, Edwards Lifesciences

In this week’s episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi talks about next week’s DeviceTalks Boston meeting with MedTech Innovator CEO Paul Grand.

We also hear interviews done earlier this year with speakers – Bertin Nahum of Quantum Surgical, Kurt Haggstrom of Synchron and Closing Keynote Speaker Rajit Kamal of Medtronic.

Anyone interested attending – and meeting a surprise surgical robotics guest – can register at Boston.DeviceTalks.com. Use the code DTWeekly25 to save 25% of the registration fee.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network.

It's Here! Share Your Story at DeviceTalks Boston Next Week Where You Can Meet Great Medtech Leaders

In this episode of AbbottTalks, Mahmood Kazemi, MD, Chief Medical Officer of Abbott’s Diabetes Care business overviews the profound advancements in diabetes management over the past decade and discusses the evolution of treatments and technological innovations that have revolutionized how individuals with diabetes approach their condition.

Further, Dr. Kazemi underscores the benefits of advancements such as the GLP-1 receptor agonists and medications that control glucose levels and offer cardiovascular and renal protection. He then elaborates on how Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems have significantly improved diabetes management. These systems provide real-time data, empowering individuals to customize their medication, diet, and activity levels with unprecedented precision. He also speaks to Abbott's ongoing and future work, including developing a state-of-the-art continuous glucose ketone monitoring (CGKM) sensor. This medical biowearable is designed to provide crucial early warning signs in Type 1 diabetes management, a significant step towards preventing dangerous complications and hospitalizations.

Looking to the future, Kazemi anticipates a wider adoption of CGM across the diabetes community, including those with type 2 diabetes, and an increase in insurer coverage.

Thank you to BMP Medical for sponsoring this episode of AbbottTalks! For more information on how BMP Medical works with medical device companies, visit www.bmpmedical.com

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott’s Kazemi discusses a decade of diabetes advancements and the impact of CGM on diabetes care

In this episode, the DeviceTalks Editorial Team - Tom Salemi, Kayleen Brown - recaps the highlights of DeviceTalks Boston with MassDevice Editor in Chief Chris Newmarker, Holly Scott of the Mullings Group, and Paul Melnychuck, Vice President & General Manager, Advanced Components at Spectrum Plastics Group, A DuPont Business.

Spectrum Plastics Group sponsored the podcast. For more information go to SpectrumPlastics.com.

Please subscribe to the DeviceTalks Podcast Network.

Hear the Final Word About DeviceTalks Boston: Live Recording of DeviceTalks Weekly On Stage

In this episode, Steve Crowe, Mike Oitzman and Eugene Demaitre discuss highlights from the 2024 Robotics Summit and Expo that took place in Boston earlier in the month. Also featured in this episode are interviews with Agility Robotics co-founder and Chief Robotics Officer, Jonathan Hurst, along with Brightpick co-founder and CEO, Jan Zizka. Agility Robotics was the inaugural RBR50 2024 Robot of the Year winner, and Brightpick was the inaugural RBR50 2024 Application of the Year winner.
See all of this years winners here: https://www.therobotreport.com/rbr50-2024/
Keep up with the latest robotics news and information here on our network of websites:
https://www.therobotreport.com/
https://mobilerobotguide.com/
https://www.cobottrends.com/

2024 Robotics Summit recap / Interviews with RBR50 Winners

In this episode of DeviceTalks Weekly, we visit with Elizabeth McCombs, executive vice president and chief technology officer at BD.

This is a replay of the opening keynote interview at DeviceTalks Boston.

This conversation comes to you courtesy of our sponsor – MTD Micro Molding. Go to MTDMicromolding.com for more information or scan the QR code.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe now to the DeviceTalks Podcast Network.

BD’s CTO Beth McCombs Explains How Medtech Innovation Can Deliver Real Help to Patients, Providers

In this episode of DeviceTalks AI, we are joined by Ha Hong, PhD, Chief Artificial Intelligence Officer of Medtronic Endoscopy about integrating AI into Medtronic's endoscopy unit, the impact on healthcare outcomes, patient-centric design, and the future of AI in the medical device industry. Watch or listen to the episode to:

- Discover how Ha's research coincided with the rise of deep learning, a pivotal technology in modern AI, and how it shaped his work in emulating visual perception processing in the brain.
- Better understand Ha's instrumental role in developing the first FDA-approved AI-powered cardiac ultrasound guidance system, a groundbreaking innovation in cardiology.
- Learn about Ha’s move to Medtronic and his vision for integrating AI into endoscopy, highlighting the potential for AI to revolutionize gastrointestinal diagnostics and treatment.
- Gain insights into Ha's philosophy of patient-centric AI design, emphasizing the importance of prioritizing patient needs and safety in AI development for healthcare.

In the episode, we also sit down with Joe Mish, VP of Sales at SmartTRAK to better understand how SmartTRAK is using AI to enhance their market intelligence solutions, combining the traditional robust analysis with advanced algorithms for more nuanced, speedier insights in the medtech industry.

This conversation comes to you courtesy of our episode sponsor, SmartTRAK. To learn more about SmartTRAK, visit www.smarttrak.com.

Please subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. 

Thank you for listening to DeviceTalks AI!

Medtronic Endoscopy's Chief AI Officer on Transforming Dx through AI and Patient-Centric Design

In this episode of The Robot Report Podcast, Steve Crowe and Mike Oitzman discuss the news of the week, then we hear recent interviews with Mike Oitzman and Ting Ming Ling, founder and CEO of OTSAW. Then we hear Eugene Demaitre interview Etienne Lacroix, CEO and founder of VENTION at the recent Robotics Summit.

Links from the show:
https://vention.io/
https://otsaw.com/camelloplus/
https://sfstandard.com/2024/05/20/waymo-foils-downtown-robbery-after-crash-cops-say/

Configuring the future of robotics

The DeviceTalks Podcast Network delivers news, insights and commentary from Medtech industry leaders. Our podcasts will inspire medtech professionals to create better medtech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 10 podcasts:

• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• DeviceTalks Weekly
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

GE HealthCare pulls back the curtain on its unmatched AI clearances; Catalyze tackles AI trust gap

DeviceTalks

Related tracks